IL-17A and IL-25: therapeutic targets for allergic and exacerbated asthmatic disease

Future Medicinal Chemistry
Bryan C Petersen, Nicholas W Lukacs

Abstract

The development of drugs targeting IL-17 family members IL-17A and IL-25 may inhibit the development of multiple components of allergic airway disease, including mucus hypersecretion, airway hypertrophy and the influx of granulocytic effector populations due to the reduction of key chemokines. It is the accumulation of these inflammatory cells that 'primes' the pulmonary environment for an exacerbated response to ubiquitous environmental allergens. Therefore, inhibiting their recruitment may reduce the incidence of severe exacerbations in asthmatic individuals.

References

Mar 22, 2002·Nature Reviews. Immunology·N W Lukacs
Sep 25, 2007·The Journal of Allergy and Clinical Immunology·Sarah J BallantyneAndrew N J McKenzie
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laura McKinleyJay K Kolls
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Erika A RickelAlison L Budelsky
Oct 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jimmy W LeeDaniel S Straus
Jul 4, 2009·Nature Reviews. Immunology·Sarah L Gaffen
Aug 8, 2009·American Journal of Respiratory and Critical Care Medicine·Rhonda H WilsonDonald N Cook
Oct 20, 2009·Nature Immunology·Lauren K ElyK Christopher Garcia
Oct 22, 2009·International Archives of Allergy and Immunology·Yang ZhaoWei Guo
Nov 6, 2009·Blood·Martin PelletierMarco A Cassatella
Jun 12, 2010·Current Topics in Medicinal Chemistry·Mary Struthers, Alexander Pasternak
Sep 22, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gerard E KaikoPaul S Foster
Sep 24, 2010·The Journal of Investigative Dermatology·Malene HvidMette Deleuran
May 17, 2011·The Journal of Allergy and Clinical Immunology·Chris J CorriganSun Ying
Jun 28, 2011·The American Journal of Pathology·Sumanta MukherjeeNicholas W Lukacs
Nov 26, 2011·Expert Review of Clinical Pharmacology·Hacer SahinHermann E Wasmuth

❮ Previous
Next ❯

Citations

Jan 4, 2013·Expert Opinion on Biological Therapy·Sabina Antonela Antoniu
Apr 30, 2014·Allergy·J L Trevor, J S Deshane
Apr 5, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Farnaz FatemiGholam Ali Kardar
Mar 1, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·X J YaoS Ying
Nov 22, 2016·Current Opinion in Allergy and Clinical Immunology·Mingyu LeeHyun-Woo Shin
Jan 25, 2021·The Journal of Allergy and Clinical Immunology·Julia BorowczykWolf-Henning Boehncke
Jun 16, 2021·Seminars in Liver Disease·Na LiTatiana Kisseleva

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.